14
Participants
Start Date
December 31, 1997
Primary Completion Date
March 31, 2001
Study Completion Date
March 31, 2001
Cordycepin
"Dose escalation study using the following doses:~6mg/m2, 12 mg/m2, 24mg/m2, 48mg/m2"
Deoxycoformycin
Dose escalation using the Fibonacci dose escalation sequence starting dose 2mg/m2, escalating to 3mg/m3 intravenous
Vincent T. Lombardi Cancer Research Center, Georgetown University, Washington D.C.
Johns Hopkins Oncology Center, Baltimore
Arthur G. James Cancer Hospital - Ohio State University, Columbus
Washington University Barnard Cancer Center, St Louis
New England Medical Center Hospital, Boston
Massachusetts General Hospital Cancer Center, Boston
Brigham and Women's Hospital, Boston
Dana-Farber Cancer Institute, Boston
Boston Medical Center, Boston
University of Massachusetts Memorial Medical Center, Worcester
Roswell Park Cancer Institute, Buffalo
Lineberger Comprehensive Cancer Center, UNC, Chapel Hill
Oregon Cancer Center at Oregon Health Sciences University, Portland
Lead Sponsor
National Cancer Institute (NCI)
NIH
Boston Medical Center
OTHER